Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation

Eric Santoni-Rugiu*, Morten Grauslund, Linea C. Melchior, Junia C. Costa, Jens B. Sørensen, Edyta M. Urbanska

*Corresponding author af dette arbejde
12 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab